Q2 2017 Holdings
Filed 2017-08-14 | 6 holdings | $78.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma Ltd.(URGN) | Common Stock | M96088105 | $26.2K | 1,451,329 | 33.5% |
| Immune Design Corp. | Common Stock | 45252L103 | $19.1K | 1,962,720 | 24.5% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common Stock | 00847L100 | $19.0K | 5,062,363 | 24.3% |
| Mersana Therapeutics, Inc. | Common Stock | 59045L106 | $13.4K | 955,709 | 17.1% |
| Eagle Pharmaceuticals, Inc.(EGRX) | Common Stock | 269796108 | $535 | 3,652,284 | 0.7% |